Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “MultiHance”

41 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 41 results

Not applicableStudy completedNCT03147989
What this trial is testing

Retrospective Study of MRI With MULTIHANCE at 0.10 and 0.05 mmol/Kg Dose in CNS Patients

Who this might be right for
Central Nervous System DiseasesCentral Nervous System Neoplasms
Bracco Diagnostics, Inc 352
Large-scale testing (Phase 3)Study completedNCT01260636
What this trial is testing

Crossover Comparison of Two Gadolinium Contrast Agents for Use With MRA of Carotid, Renal and Peripheral Arteries

Who this might be right for
Carotid, Aortic, Renal or Peripheral Artery Disease
Bracco Diagnostics, Inc 120
Post-approval studies (Phase 4)Study completedNCT00395863
What this trial is testing

Multihance at 3 Tesla (3T) in Brain Tumors

Who this might be right for
Brain Tumor
Bracco Diagnostics, Inc 46
Large-scale testing (Phase 3)Ended earlyNCT00323310
What this trial is testing

Safety and Efficacy of MultiHance in Pediatric Patients

Who this might be right for
Central Nervous System Diseases
Bracco Diagnostics, Inc 92
Large-scale testing (Phase 3)Study completedNCT00185276
What this trial is testing

Magnevist® Injection Enhanced MRA at Two Dose Levels Compared to Non Contrast MRA for the Detection of Structural Abnormalities of the Infrarenal Aorta and Peripheral Arteries

Who this might be right for
Peripheral Vascular Disease
Bayer 365
Not applicableEnded earlyNCT02095353
What this trial is testing

Comparison of Contrast Agents for MRI Perfusion Analysis in Brain Tumor Patients

Who this might be right for
Central Nervous System Neoplasms
University of Nebraska 6
Not applicableStudy completedNCT03108378
What this trial is testing

Evaluation of Gd Retention in Human Bone and Skin After MultiHance or ProHance Administration Compared With Control

Who this might be right for
Gadolinium Retention
Bracco Diagnostics, Inc 28
Not applicableStudy completedNCT00600951
What this trial is testing

Evaluation of the Risk of NSF Following MultiHance Injection in Patients With Chronic Kidney Disease

Who this might be right for
Renal Insufficiency
Bracco Diagnostics, Inc 366
Large-scale testing (Phase 3)Study completedNCT00395460
What this trial is testing

Efficacy and Safety Study to Evaluate Gadavist (Gadobutrol) as Contrast Agent in Magnetic Resonance Imaging (MRI) of Brain or Spine Diseases in Chinese Patients

Who this might be right for
Central Nervous System Diseases
Bayer 147
Post-approval studies (Phase 4)Ended earlyNCT04973007
What this trial is testing

Comparison of Contrast Agents in Liver Magnetic Resonance (MR) for the Detection of Hepatic Metastases

Who this might be right for
Oligometastatic DiseaseLiver MetastasesColorectal Cancer
University of Colorado, Denver 10
Large-scale testing (Phase 3)Study completedNCT00408083
What this trial is testing

Crossover Study With MultiHance vs a Comparator for Peripheral MRA

Who this might be right for
Peripheral Vascular Disease
Bracco Diagnostics, Inc 100
Not applicableStudy completedNCT01376739
What this trial is testing

Magnevist Post-marketing Surveillance in Japan

Who this might be right for
Diagnostic Imaging
Bayer 2,051
Not applicableStudy completedNCT02226666
What this trial is testing

Physiologic Assessment Following Gadoxetic Acid and Gadobenate Dimeglumine Administration

Who this might be right for
Liver Tumor
University of Michigan 107
Large-scale testing (Phase 3)Study completedNCT01050829
What this trial is testing

Gadobutrol Magnevist-controlled Body Study

Who this might be right for
Magnetic Resonance Imaging
Bayer 370
Testing effectiveness (Phase 2)Study completedNCT00652418
What this trial is testing

Magnevist (SH L 451A) Intra-individual Dose Comparison Study in Magnetic Resonance Angiography

Who this might be right for
Magnetic Resonance AngiographyPeripheral Vascular DiseasesPeripheral Arterial Diseases
Bayer 12
Not applicableUnknownNCT02992847
What this trial is testing

Evaluation of Potential Accumulation of Gadolinium (Dotarem and Multihance) in the French Observatory of Multiple Sclerosis (Www.Ofsep.Org/)

Who this might be right for
Multiple Sclerosis
Hospices Civils de Lyon 160
Not applicableStudy completedNCT00539253
What this trial is testing

Assessment of Liver Cancer Response to TACE Using MultiHance-Enhanced MRI.

Who this might be right for
Hepatocellular Carcinoma
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 45
Early research (Phase 1)Study completedNCT00411931
What this trial is testing

A Pharmacokinetics Study of MultiHance in Pediatric Patients

Who this might be right for
Central Nervous System Pathology
Bracco Diagnostics, Inc 15
Post-approval studies (Phase 4)Study completedNCT02070380
What this trial is testing

Crossover Comparison of MultiHance and Dotarem

Who this might be right for
Brain Disease
Bracco Diagnostics, Inc 179
Large-scale testing (Phase 3)Study completedNCT00310557
What this trial is testing

Magnevist® Injection-enhanced MRA Compared to Non Contrast MRA for the Detection of Stenosis of the Renal Arteries

Who this might be right for
Renal Artery Stenosis
Bayer 116
Load More Results